Spotlight on Proteic Bioscience
PROTEIC BIOSCIENCE INC. is an emerging leader in the field of applying advanced artificial intelligence technology to complex drug discovery. PROTEIC is engineering the next generation of drugs more rapidly and efficiently, inventing new approaches to drug discovery by implementing precision data generation and analytics, creating an integrated biopharma machine-learning system to re-imagine new and better drugs enabling faster and better care to patients worldwide.
Website: www.proteic.ai
- INVENTING NEW APPROACHES to drug discovery by combining AI science with experimental innovation - re-imagining new and better drugs.
- EMERGING AS A LEADER in the field of applying advanced AI to complex drug discovery by engineering the next generation of drugs more rapidly and efficiently.
- BUILDING A DEEP-STACK PLATFORM by implementing both AI design and precision data generation, creating an integrated biopharma machine-learning system.
- ACCELERATING PRE-CLINICAL DRUG DISCOVERY, enabling faster and better care to patients worldwide.
- BUILDING A PORTFOLIO OF PROTEIC owned drug targets including diseases that were historically considered undruggable.
Recording
Attachments
Speakers
About
At PROTEIC we set out to create a unique culture that unites individuals from diverse backgrounds – life scientists, data scientists and engineers – into a single team. Our predictive models start by deriving insights from genetic, phenotypic, and clinical data, using machine learning to increase the power of traditional analyses moving us closer to the underlying architecture and biology of disease. Our molecular insights are the critical first step towards building truly predictive disease models that capture causal biology. Our AI technology platform harnesses advanced computational mathematics which takes us beyond the limitations of traditional biochemistry, rapidly generating massive high-quality data and scaling deeper into the diversity of human disease and potential therapies.